Travere Therapeutics Inc (NASDAQ:TVTX)
| 27.74 BATS BZX Real-Time Price As of 10:30am ET |  +0.16 / +0.58%Today’s Change | 17.05 Today|||52-Week Range 31.65 | -10.63% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Aselage Stephen J Director |  Buy | 10/07/2021 | 60,000 | $16.23 | $973.8K | +6.03% |
Aselage Stephen J Director |  Sale | 11/16/2021 | 31,800 | $29.39 | $934.6K | -6.38% |
Aselage Stephen J Director | Sale | 10/07/2021 | 32,000 | $26.26 | $840.3K | +6.03% |
Aselage Stephen J Director | Sale | 10/07/2021 | 28,000 | $26.23 | $734.4K | +6.03% |
Dube Eric /glaxosmithkline/ Chief Executive Officer | Sale | 1/05/2022 | 10,361 | $29.84 | $309.2K | -5.80% |
Aselage Stephen J Director | Sale | 11/05/2021 | 10,000 | $26.23 | $262.3K | -8.34% |
Clague Laura M Chief Financial Officer | Sale | 1/11/2022 | 7,500 | $27.40 | $205.5K | -0.29% |
Dube Eric /glaxosmithkline/ Chief Executive Officer | Sale | 1/24/2022 | 7,873 | $24.98 | $196.7K | +6.40% |
Aselage Stephen J Director | Buy | 11/05/2021 | 10,000 | $16.23 | $162.3K | -8.34% |
Aselage Stephen J Director | Sale | 11/01/2021 | 5,000 | $29.48 | $147.4K | -6.79% |
Page of 5